Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hanmi and AngioLab enter licensing agreement

Feb. 20, 2012

Chinese company divulges new GPR119 receptor agonists and DPP IV inhibitors

Feb. 17, 2012

Takeda reports novel NF-kappa-B activation inhibitors

Feb. 17, 2012

FDA approves new gel for male hypogonadism

Feb. 16, 2012

Glenveigh Medical digoxin antidote gets orphan drug designation

Feb. 16, 2012

Recruitment begins in phase II ISIS-APOCIIIRx trial

Feb. 16, 2012

Trimel provides update on intranasal gel for female anorgasmia

Feb. 16, 2012

Columbia Laboratories transfers progesterone vaginal gel NDA

Feb. 15, 2012

New phase III data support once-weekly exenatide use for diabetes type 2

Feb. 15, 2012

Amarin gives update on FDA's review of AMR-101 NDA

Feb. 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...